We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
14 hedge funds and large institutions have $3.94M invested in Windtree Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
56% more funds holding
Funds holding: 9 → 14 (+5)
45% more capital invested
Capital invested by funds: $2.72M → $3.94M (+$1.23M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
–
Closed
3
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$292K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$195K |
| 3 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$195K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$195K |
| 5 |
BlackRock
New York
|
+$97.3K |
Top Sellers
| 1 |
AAA
Affinity Asset Advisors
New York
|
-$105K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$97.3K |
| 3 |
HF
HRT Financial
New York
|
-$57K |
| 4 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$9K |
